Karyopharm endometrial cancer trial misses primary endpoint

Karyopharm endometrial cancer trial misses primary endpoint

Karyopharm endometrial cancer trial misses primary endpoint
Key insight: Bankers in the U.S. can learn a few things from watching the rollout of the EU’s new AI Act. Specifically, they should notice the gaping hole where rules about identity verification ought to be. What’s at stake: The banking industry has spent years building systems around the idea that someone’s voice, and/or face,…
Mayor Zohran Mamdani describes new CEO Anthony Shorris and Chair Lina Khan as a “dream team” atop the EDC, but they are also an odd pairing. A mild-mannered McKinsey & Co. partner and firebrand ex-Federal Trade Commission chair aren’t the typical duo to hold the reins of the city’s most powerful business agency and its…
Stop-loss strategies for new investors, illustrated with Apple stock
When people ask me what causes the most damage in a relationship, they expect me to list out the usual suspects, like financial trouble or intimacy problems. And they’re not wrong to guess that, since both money and sex come up constantly in research on conflict. But as a psychologist who’s spent years studying couples,…
Billionaire Peter Thiel’s hedge fund, Thiel Macro, disclosed its latest portfolio in a regulatory filing last month, and the fund’s largest reported position (a stake worth about $118 million as of June 30) is e-commerce and cloud computing giant Amazon (AMZN -0.15%). But I’d argue the filing itself is less notable than the track record…
Fidelity will relocate its official headquarters to South Boston’s Commonwealth Pier as the financial services behemoth preps to return its employees to the office full-time. A Fidelity spokesperson told the Boston Business Journal that the company plans to file regulatory paperwork to name the building in the Seaport neighborhood as its new headquarters but could…